← Insiders

QTEX

Neutral signalScored 2026-10-21 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.

Research, not advice.

À propos

QTREX Quantum Ltd.

Nom
QTREX Quantum Ltd.
Secteur
Technology
Industrie
Computer Hardware
Bourse
NASDAQ
Capitalisation
$60.4M
Employés
34
PDG
Dagi Shahar Ben-Noon
Site web
https://www.q-trex.com
Marché
—

QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. The company provides the INSPIRA ART100, a vital life support system designed for cardiopulmonary bypass procedures lasting up to six hours. Additionally, it offers the HYLA blood sensor, engineered to deliver real-time sampling and analysis of critical blood parameter measurements. Founded in 2018, the company previously operated as Inspira Technologies Oxy B.H.N. Ltd. before rebranding to QTREX Quantum Ltd. in May 2026. Its primary operations are headquartered in Ra'anana, Israel.

Price (1 year)

Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.

ACHAT TOTAL: 193 741 titres (~159 904,44 $ US)

Insiders
Parnes TalBen-Noon Dagi Shahar
Total bought
$159,904

Avg buy (VWAP, 90d window) $0.83 vs last close $1.29 (+56.3%)

Total sold
—

Avg sell (VWAP, 90d window) —

Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.

Last activity
2026-10-15
Liquidity
Liquid $31,467,892/day · 20d vol
Last synced
2026-10-26 21:10:53 Synced via automated research pipeline

Sign in to request a sync of this company's price history and timing levels.

Insider holdings as a share of total assets aren't available for this company.

Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.

Recent Form 4

Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.

Date Person Side Shares Price Value Form 4
2026-10-15 Parnes Tal Buy · P 6,666 $1.50 $9,999 Form 4
2026-10-09 Ben-Noon Dagi Shahar Buy · P 18,181 $1.67 $30,362 Form 4
2026-09-28 Ben-Noon Dagi Shahar Buy · P 168,894 $0.71 $119,543 Form 4

Congressional trades

STOCK Act disclosures (90-day window)

Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.

No STOCK Act disclosures for this company in this window.

Signal

Neutral signalScored 2026-10-21 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.

QTEX exhibits a compelling event-driven catalyst — a significant insider cluster buy (~$160k) paired with Nasdaq compliance regain and independent technology validation — but the complete absence of financial…

The first sentence of the analysis written for QTEX on 2026-10-21 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Neutral signal Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.

Factor checklist — research, not advice

A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.

  • Insider Supports a bullish reading. Open-market purchases outweigh sales
  • Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
  • Congress Unavailable or mixed. No purchase disclosures in the stored window
  • Timing Supports a bullish reading. Interesting trend — weekly bias up
  • Financial indicators Unavailable or mixed. No liquidity or margin figures stored

Suggested stop 0.71, nearest stored support minus 0.5 ATR(44.9% under the last close). Reward/risk to the next stored resistance is 0.10. Wait — that reward/risk is under 2. Research, not advice. Not an order.

Recent news

Market snapshot

Financial ratios

No ratio data synced.

Key metrics

No metrics data synced.

Employee count

No employee-count data synced.

Peer market caps

No peer data synced.